Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis
- 1 January 2004
- journal article
- Published by Elsevier in The Lancet
- Vol. 363 (9405), 320-324
- https://doi.org/10.1016/s0140-6736(03)15394-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shiftTuberculosis, 2003
- Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, PeruNew England Journal of Medicine, 2003
- Antiretroviral treatment in resource-poor settings: clinical research prioritiesThe Lancet, 2002
- Increasing transparency in partnerships for health – introducing the Green Light CommitteeTropical Medicine & International Health, 2002
- Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in PeruThe Lancet, 2002
- Treatment Experience of Multidrug-Resistant Tuberculosis in Florida, 1994–1997Chest, 2001
- Responding to Market Failures in Tuberculosis ControlScience, 2001
- Drug-resistant tuberculosis: desperate measures?The Lancet, 2001
- Outcome of Multi-drug-resistant Tuberculosis in FranceAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Multidrug-Resistant Tuberculosis in Patients without HIV InfectionNew England Journal of Medicine, 1995